메뉴 건너뛰기




Volumn 5, Issue 6, 2004, Pages 567-584

Monitoring cell therapy using iron oxide MR contrast agents

Author keywords

Iron oxide; MR contrast agent; Myelin; Myocardial infarction; Neurodegeneration; Progenitor cell; Stem cell

Indexed keywords

BETA GALACTOSIDASE; BETA GLUCURONIDASE; CARBON 11; CYCLOSPORIN; DENDRIMER; DESMIN; DIVINYLBENZENE; DOPAMINE 2 RECEPTOR; GADOLINIUM; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; IRON OXIDE; LECTIN; LIPOFECTAMINE; LIPOSOME; MICROSPHERE; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; MYELIN; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; OLIGONUCLEOTIDE; POLYLYSINE; RACLOPRIDE; RECEPTOR ANTIBODY; RETINOIC ACID; STYRENE; SUPERFECT; SUPERPARAMAGNETIC IRON OXIDE; TRANSACTIVATOR PROTEIN; TRANSFERRIN RECEPTOR; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNINDEXED DRUG;

EID: 10644286399     PISSN: 13892010     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389201043376526     Document Type: Review
Times cited : (162)

References (166)
  • 23
    • 0036158610 scopus 로고    scopus 로고
    • Wolswijk, G. (2002) Brain 125, 338-349.
    • (2002) Brain , vol.125 , pp. 338-349
    • Wolswijk, G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.